Sandra Del Pozo Collado

6PUBLICATIONS
28CO-AUTHORS
Disease surveillanceAllergyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Real-World Effectiveness of Polymerized House-Dust-Mite Subcutaneous Immunotherapy up to 24 Months: Why Baseline Symptom Severity Shapes Measurement of the Combined Symptom-Medication Response.

|Jul 28, 2026
Subcutaneous Immunotherapy with Mannan-Conjugated Birch Pollen Allergoids in a Pre- and Co-Seasonal Treatment Regimen: An Exploratory Post Hoc Subgroup Analysis of Safety and Tolerability.

|Apr 30, 2026
Sustained Clinical Improvement in Birch Pollen Allergy After Two Pre-Seasonal Short Courses of Allergen-Specific Immunotherapy: A Long-Term Open-Label Extension Study.

|Dec 11, 2025
Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment.

Sandra Del Pozo, Natascha Wahrhusen, Oliver Pfaar

|Nov 09, 2024
Short-course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy.

Ralph Mösges, Esther Raskopf, Ludger Klimek

|May 16, 2022
First-in-human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy.

Antonio Nieto, Ángel Mazón, María Nieto

Pageof 1

Frequent Collaborators

6 joint publications

Miguel Casanovas

5 joint publications

José Luis Subiza

4 joint publications

Mandy Cuevas

4 joint publications

Anna Rybachuk